Chloraprep With Tint Patent Expiration

Chloraprep With Tint is a drug owned by Becton Dickinson And Co. It is protected by 8 US drug patents filed in 2013. Out of these, 1 drug patents are active and 7 have expired. Based on its patents and exclusivities, its generic launch date is estimated to be Apr 25, 2027. Details of Chloraprep With Tint's patents and their expiration are given in the table below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
These drug patents focus on the other aspects of the drug like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7422388 Applicator for coloring antiseptic
Apr, 2027

(2 years from now)

Active
US6991393 Liquid applicator for coloring a liquid
Mar, 2023

(1 year, 9 months ago)

Expired
US6991394 Liquid applicator with a mechanism for fracturing multiple ampoules
Jan, 2024

(10 months ago)

Expired
US7182536 Antiseptic applicator with mechanism for fracturing multiple ampoules
Dec, 2023

(11 months ago)

Expired
US6729786 Liquid applicator for coloring a liquid
Mar, 2023

(1 year, 9 months ago)

Expired
US7241065 Applicator for coloring antiseptic
Mar, 2023

(1 year, 9 months ago)

Expired
US6536975 Liquid applicator with opposed wings
Nov, 2020

(4 years ago)

Expired
US5690958 Unit dose chlorhexadine gluconate(CHG) applicator having extended CHG shelf life
Sep, 2016

(8 years ago)

Expired


A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Chloraprep With Tint's patents.

Given below is the list of recent legal activities going on the following patents of Chloraprep With Tint.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 12th Year, Large Entity 19 Feb, 2020 US7422388
Payment of Maintenance Fee, 12th Year, Large Entity 19 Dec, 2018 US7241065
Payment of Maintenance Fee, 12th Year, Large Entity 20 Jul, 2018 US7182536
Entity Status Set To Undiscounted (Initial Default Setting or Status Change) 26 Aug, 2010 US7182536
Change in Power of Attorney (May Include Associate POA) 29 Sep, 2009 US6729786
Change in Power of Attorney (May Include Associate POA) 28 Sep, 2009 US7241065
Change in Power of Attorney (May Include Associate POA) 28 Sep, 2009 US6991393
Change in Power of Attorney (May Include Associate POA) 24 Sep, 2009 US6991394
Change in Power of Attorney (May Include Associate POA) 24 Sep, 2009 US7182536
Correspondence Address Change 23 Sep, 2009 US7241065

Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.

Get the exclusive patent insights now. Don't be the last to know.

US patents provide insights into the exclusivity only within the United States, but Chloraprep With Tint is protected by patents in multiple countries. Understanding the full scope of patent protection is crucial in strategizing market entry. By looking at the broader patent landscape, you can identify markets with weaker patent protection which could be ideal generic entry points. The following section offers details on Chloraprep With Tint's family patents as well as insights into ongoing legal events on those patents.

Chloraprep With Tint's Family Patents

Chloraprep With Tint has patent protection in a total of 12 countries. It's US patent count contributes only to 35.7% of its total global patent coverage. Click below to unlock the full patent family tree for Chloraprep With Tint.

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List


Generic Launch

Generic Release Date:

Chloraprep With Tint's generic launch date based on the expiry of its last outstanding patent is estimated to be Apr 25, 2027 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)

Chloraprep With Tint Generics:

There are no approved generic versions for Chloraprep With Tint as of now.

Alternative Brands for Chloraprep With Tint

Chloraprep With Tint which is used for sterilizing the patient's skin before surgery., has several other brand drugs in the same treatment category and using the same active ingredient (Chlorhexidine Gluconate; Isopropyl Alcohol). Given below is the list of those companies and their brand drugs, to help you identify new opportunities, assess competitors, and plan your market strategies more effectively.

Drug Owner Drug Name Treatment Area
Zurex Pharma
Zuragard Used for skin preparation prior to surgery.

Apart from drugs working in same treatment category, there are also some brand drugs where treatment area is different, but the active ingredient used is same i.e. Chlorhexidine Gluconate; Isopropyl Alcohol. Given below is the list of those drugs and companies owning them.







About Chloraprep With Tint

Chloraprep With Tint is a drug owned by Becton Dickinson And Co. It is used for sterilizing the patient's skin before surgery. Chloraprep With Tint uses Chlorhexidine Gluconate; Isopropyl Alcohol as an active ingredient. Chloraprep With Tint was launched by Becton Dickinson Co in 2000.

Approval Date:

Chloraprep With Tint was approved by FDA for market use on 14 July, 2000.

Active Ingredient:

Chloraprep With Tint uses Chlorhexidine Gluconate; Isopropyl Alcohol as the active ingredient. Check out other Drugs and Companies using Chlorhexidine Gluconate; Isopropyl Alcohol ingredient

Treatment:

Chloraprep With Tint is used for sterilizing the patient's skin before surgery.

Dosage:

Chloraprep With Tint is available in sponge form for topical use. Given below is detailed information on Dosage -

Strength Dosage Form Availability Application Pathway
2%;70% (26ML) SPONGE Over the counter TOPICAL
2%;70% (10.5ML) SPONGE Over the counter TOPICAL
2%;70% (3ML) SPONGE Over the counter TOPICAL